A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older

Eisai

Status: Completed

Conditions: Epilepsy; Partial Onset Seizures

Treatments: Drug: Perampanel

Study type: Observational

Funder types: Industry

Identifiers

NCT03836924

E2007-M091-508

Details and patient eligibility

About

The purpose of this study is to assess the safety of perampanel in the treatment of partial onset seizures in participants of age 12 years and older with epilepsy.

Enrollment: 200 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants prescribed perampanel for the adjunctive treatment of partial onset seizures based on independent clinical judgment of treating physicians.

Exclusion criteria

• Participation in another study involving administration of an investigational drug or device whilst participating in this observational study.
• Hypersensitivity [allergic] to perampanel.

Trial design

200 participants in 1 patient group

Perampanel

Description:

Participants receiving perampanel tablets, orally according to prescribing information and the treating physician's clinical judgment will be observed prospectively for up to 6 months or participant withdrawal, whichever occurs first.

Treatment:

Drug: Perampanel